SEC Comment Letter 0000000000-24-003725 to Perspective Therapeutics, Inc. (CATX) (CIK 0000728387) (CATX)

Perspective Therapeutics, Inc. (CATX) (CIK 0000728387)
Date: April 8, 2024 · CIK: 0000728387 · Accession: 0000000000-24-003725

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-278362

Date

April 8, 2024

Author

Not clearly detected

Form

UPLOAD

Company

Perspective Therapeutics, Inc. (CATX) (CIK 0000728387)

Letter

United States securities and exchange commission logo April 8, 2024 Johan (Thijs) Spoor Chief Executive Officer Perspective Therapeutics, Inc. 2401 Elliott Avenue, Suite 320 Seattle, WA 98121 Re:Perspective Therapeutics, Inc. Registration Statement on Form S-3 Filed March 29, 2024 File No. 333-278362 Dear Johan (Thijs) Spoor: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Conlon Danberg at 202-551-4466 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Stephen Nicolai, Esq.

Show Raw Text

United States securities and exchange commission logo
April 8, 2024
Johan (Thijs) Spoor
Chief Executive Officer
Perspective Therapeutics, Inc.
2401 Elliott Avenue, Suite 320
Seattle, WA 98121
Re:Perspective Therapeutics, Inc.
Registration Statement on Form S-3
Filed March 29, 2024
File No. 333-278362
Dear Johan (Thijs) Spoor:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Conlon Danberg at 202-551-4466 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc:       Stephen Nicolai, Esq.

SecProbe.io